BioDelivery Sciences International Inc. (BDSI) Given a $6.00 Price Target by Roth Capital Analysts


The brokerage currently has a buy rating on the specialty pharmaceutical company's stock. A number of other brokerages also recently issued reports on BDSI.



from Biotech News